These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1399 related articles for article (PubMed ID: 33765919)

  • 1. Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
    Almofti YA; Abd-Elrahman KA; Eltilib EEM
    BMC Immunol; 2021 Mar; 22(1):22. PubMed ID: 33765919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
    Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
    Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
    Jakhar R; Kaushik S; Gakhar SK
    J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
    Marchan J
    J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
    Yang Z; Bogdan P; Nazarian S
    Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
    Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
    Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
    Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
    Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
    Oliveira SC; de Magalhães MTQ; Homan EJ
    Front Immunol; 2020; 11():587615. PubMed ID: 33193414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.
    Tahir Ul Qamar M; Rehman A; Tusleem K; Ashfaq UA; Qasim M; Zhu X; Fatima I; Shahid F; Chen LL
    PLoS One; 2020; 15(12):e0244176. PubMed ID: 33351863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.
    Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Lee SS; Chakraborty C
    J Med Virol; 2020 Jun; 92(6):618-631. PubMed ID: 32108359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
    Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
    Front Immunol; 2021; 12():692937. PubMed ID: 34497604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel strategy for developing vaccine candidate against Jaagsiekte sheep retrovirus from the envelope and gag proteins: an in-silico approach.
    Mahmoud NA; Elshafei AM; Almofti YA
    BMC Vet Res; 2022 Sep; 18(1):343. PubMed ID: 36085036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes.
    Jain N; Shankar U; Majee P; Kumar A
    Infect Genet Evol; 2021 Jan; 87():104648. PubMed ID: 33264668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering receptor-binding domain and heptad repeat domains towards the development of multi-epitopes oral vaccines against SARS-CoV-2 variants.
    Arshad NF; Nordin FJ; Foong LC; In LLA; Teo MYM
    PLoS One; 2024; 19(8):e0306111. PubMed ID: 39146295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico discovery of antigenic proteins and epitopes of SARS-CoV-2 for the development of a vaccine or a diagnostic approach for COVID-19.
    Can H; Köseoğlu AE; Erkunt Alak S; Güvendi M; Döşkaya M; Karakavuk M; Gürüz AY; Ün C
    Sci Rep; 2020 Dec; 10(1):22387. PubMed ID: 33372181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An
    Dar HA; Waheed Y; Najmi MH; Ismail S; Hetta HF; Ali A; Muhammad K
    J Immunol Res; 2020; 2020():8893483. PubMed ID: 33274246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification B and T-Cell epitopes and functional exposed amino acids of S protein as a potential vaccine candidate against SARS-CoV-2/COVID-19.
    Tohidinia M; Sefid F
    Microb Pathog; 2020 Nov; 148():104459. PubMed ID: 32835775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine.
    Shehata MM; Mahmoud SH; Tarek M; Al-Karmalawy AA; Mahmoud A; Mostafa A; M Elhefnawi M; Ali MA
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
    Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
    Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.